NG

Nimish Gupta

Active Director Director DIN 01211133
DIN 01211133 First appointment Feb 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2007
Shareholding value •••• Premium profile

About Nimish Gupta

Data last updated:

Nimish Gupta is a Director at Sgs Pharmaceutical Pvt Ltd (since 2007). The company operates in Pharma. Sgs Pharmaceutical Pvt Ltd reported revenue of ₹58.96 Cr (FY 2024).

DIN 01211133
Primary Designation Director
Industry Pharma
First Appointment 20 Feb 2007
Oldest Company Age 25 yrs
Largest company Sgs Pharmaceutical Pvt Ltd · ₹58.96 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sgs Pharmaceutical Pvt Ltd U24239DL2001PTC110738
Director20 Feb 20072001₹58.96 Cr (FY 2024)Active

Board colleagues of Nimish Gupta

NameDINCompanyDesignation
Manvendra Singh08345551Sgs Pharmaceutical Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Sgs Pharmaceutical Pvt Ltd
Premium access

Shareholding and investment profile for Nimish Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimish Gupta

Nimish Gupta currently holds 1 directorship: Sgs Pharmaceutical Pvt Ltd (Director, since 20 Feb 2007, revenue ₹58.96 Cr (FY 2024)).

Nimish Gupta was first appointed on 20 Feb 2007 as Director at Sgs Pharmaceutical Pvt Ltd.

The current boards of Nimish Gupta's companies include Manvendra Singh (Sgs Pharmaceutical Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available